ENDRA Life Sciences Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
ENDRA Life Sciences Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2016 to Q3 2024.
  • ENDRA Life Sciences Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.35M, a 24.1% increase year-over-year.
  • ENDRA Life Sciences Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$8.82M, a 25.8% increase year-over-year.
  • ENDRA Life Sciences Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$10.1M, a 23.7% increase from 2022.
  • ENDRA Life Sciences Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$13.2M, a 17.3% decline from 2021.
  • ENDRA Life Sciences Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$11.2M, a 4.22% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$8.82M -$2.35M +$747K +24.1% Jul 1, 2024 Sep 30, 2024 10-Q/A 2024-11-21
Q2 2024 -$9.57M -$2.23M +$328K +12.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$9.89M -$2.78M +$167K +5.68% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$10.1M -$1.46M +$1.83M +55.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$11.9M -$3.1M +$339K +9.87% Jul 1, 2023 Sep 30, 2023 10-Q/A 2024-11-21
Q2 2023 -$12.2M -$2.56M +$1.03M +28.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$13.3M -$2.94M -$84.5K -2.96% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$13.2M -$3.29M -$185K -5.96% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$13M -$3.44M -$782K -29.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$12.2M -$3.59M -$392K -12.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$11.8M -$2.86M -$589K -26% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$11.2M -$3.1M -$854K -37.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$10.4M -$2.66M +$600K +18.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$11M -$3.2M -$305K -10.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$10.7M -$2.27M +$1.05M +31.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$11.7M -$2.25M +$2.56M +53.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$14.3M -$3.26M +$155K +4.56% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$14.4M -$2.89M -$560K -24% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$13.9M -$3.32M -$574K -20.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$13.3M -$4.81M -$2.44M -103% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$10.9M -$3.41M -$655K -23.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$10.2M -$2.33M -$488K -26.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$9.72M -$2.75M +$76.6K +2.71% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$9.8M -$2.37M -$71K -3.09% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$9.73M -$2.76M -$1.85M -204% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$7.88M -$1.85M -$415K -29% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$7.46M -$2.83M -$2.08M -281% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$5.38M -$2.29M -$1.61M -233% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-11
Q3 2017 -$3.77M -$909K +$69K +7.06% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$3.84M -$1.43M -$703K -96.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$3.14M -$742K -$362K -95.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$2.78M -$689K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-20
Q3 2016 -$978K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$729K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$379K Jan 1, 2016 Mar 31, 2016 10-Q 2017-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.